insurance reimbursements

High Tamiflu Costs Hurting Patients and Pharmacists
High Tamiflu Costs Hurting Patients and PharmacistsMany pharmacists claim low reimbursement rates for Tamiflu and many patients are being left with high costs.
Getting Reimbursed for Services Rendered: It’s no Magic TrickPharmacists use their expertise to help patients -- as well as insurance companies. But we do it for free!
The future of pharmacy is finally hereThat would be MTM. And it's calling. And holding. And holding. And holding ...
Shrinking insurance formulary limits Rx optionsDermatology is truly unique in patient satisfaction, but I am concerned that our ability to deliver this high level of performance is being eroded by factors beyond our control. learn more
The Perinatal Episode of Care Model: How will it affect you and your high-risk patients?Limited patient access to care and financial penalties to high-risk providers may be unintended consequences of this payment system.
Payment reform shifts to high gear
Payment reform shifts to high gearAfter several years of uneven progress, the pace of healthcare payment reform shifted into high gear in January when the U.S Department of Health and Human Services (HHS) announced plans to tie 30% of traditional, or fee-for-service, Medicare payments to quality or value alternative payment models by the end of 2016, and 50% by the end of 2018.
Understanding the costs of genetic testing for ocular diseaseAn article recently published in Current Opinion in Ophthalmology looked to help eyecare practitioners understand the costs of genetic testing in ocular disease, the complexities of insurance coverage, and its impact on the availability of genetic testing.
Games insurers playInsurance carriers just do not cover compounded medications — any compound — for any reason. Why? Because they do not want to.
Increase patient collections by developing a policy for successWith high deductible health plans on the rise, patients are expected to shoulder more of the cost of healthcare; yet practices are finding it difficult to collect. In part because patients don't understand their plans; but also because staff may be unprepared to collect patient obligations.
New study says cancer survivors incur debt and have to tap alternate sources of income to pay for treatmentThe average cancer survivor with insurance incurs $712 in monthly bills for physician copayments, prescription drugs and other expenses related to treatment, according to a new study from Washington National’s Institute for Wellness Solutions.